Pharmaceutical giant PT Kalbe Farma (KLBF) Tbk posted unaudited net profit of Rp2.13 trillion in 2010, grew 37% from Rp1.56 trillion in 2009, Investor Daily reported this morning.
Vidjongtius, KLBF's finance director, said the company's revenue rose 12.2% to Rp10.2 trillion from Rp9 trillion a previous year, mainly supported by revenue from business division.
He said revenue of nutrition products (Zee brand milk) increased 18%, accounts for 22% of total revenue. "Revenue from medicine distribution managed by our subsidiary (PT Enseval Putera Megatrading Tbk) also grew 14%," Vidjongtius said, noting the distribution division contributed 36% of total revenue.
While, he said, KLBF's medicine sales (both prescription and OTC medicines) rose 16% and contributed 25% of total revenue.
For 2011, Vidjongtius said the company targets profit to grow 15-17% on expected revenue of Rp11.6 trillion. He said the company will launche 10 new products this year to help boost the revenue.
Vidjongtius said KLBF allocates capital expenditure (capex) of Rp600-650 billion for this year, funded by internal cash.
He said revenue of nutrition products (Zee brand milk) increased 18%, accounts for 22% of total revenue. "Revenue from medicine distribution managed by our subsidiary (PT Enseval Putera Megatrading Tbk) also grew 14%," Vidjongtius said, noting the distribution division contributed 36% of total revenue.
While, he said, KLBF's medicine sales (both prescription and OTC medicines) rose 16% and contributed 25% of total revenue.
For 2011, Vidjongtius said the company targets profit to grow 15-17% on expected revenue of Rp11.6 trillion. He said the company will launche 10 new products this year to help boost the revenue.
Vidjongtius said KLBF allocates capital expenditure (capex) of Rp600-650 billion for this year, funded by internal cash.
Tidak ada komentar:
Posting Komentar